Running a Marathon Can Be Bad for the Heart, Especially in Less Prepared Runners, Say Experts
Philadelphia, PA, October 9, 2013 – Investigators who studied a group of recreational marathon runners have established that strenuous exercise such as running a marathon can damage the heart muscle. Although they found the effect is temporary and reversible, they warn that these effects are more widespread in less fit distance runners and that recreational distance runners should prepare properly before marathons. Their findings are published in the October issue of the Canadian Journal of Cardiology.
Previous reports have established that a significant percentage of sports competitors show signs of heart muscle injury and cardiac abnormalities after prolonged exercise. In a new study designed to evaluate what kind of stress running a marathon puts on the heart, and whether this might cause permanent damage, investigators evaluated 20 recreational distance runners aged between 18 and 60 who were scheduled to take part in the Quebec City Marathon and who had no known cardiovascular disease or drug treatment. The participants were all amateur runners. Those who had run another marathon less than two months before recruitment or during the study period were excluded.
The runners were extensively observed and tested six to eight weeks before the marathon and on the day itself. They were tested again within 48 hours after completing the marathon, including a second MRI study and final blood sampling. This timeframe guaranteed adequate rehydration (assessed according to hemoglobin level) and a return to baseline hemodynamic state (assessed according to heart rate and blood pressure) after the race, but was short enough to observe any significant myocardial changes before recovery. All runners with decreased left ventricular ejection fraction (LVEF), a measure of cardiac pumping efficiency, after the race compared with baseline underwent a third MRI study after three months of rest to check whether it had reversed.
Investigators noted that the race induced a decrease in left and right ventricular function in half of the amateur distance runners. When a lot of the heart was affected, the heart also showed swelling and reduced blood flow. “We first established that marathon related segmental function decrease – observed in more than half of all segments – is associated with a decrease in resting perfusion and increase in myocardial edema,” observes senior author Eric Larose, DVM, MD, FRCPC, FAHA, of the Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), Canada. “We also found that heart muscle changes were more common and widespread in runners with lower fitness and less training. Finally, we observed that these changes were transient,” he continues.
The investigators do not believe these temporary changes are a cause for concern. “Segmental function decrease is associated with poor prognosis in the presence of CAD or cardiomyopathy. Segmental dysfunction also indicates a poor prognosis in adults without cardiovascular disease. Although we don’t know whether such changes mean that recreational runners are at risk, the attendant edema, and reduced perfusion suggest transient injury,” says Larose.
“The changes are more widespread among those with lower fitness levels and less training,” observes Larose, who is professor of medicine at Université Laval and a cardiologist and clinical researcher at IUCPQ. “Although no permanent injury was observed in this group of runners, the findings suggest that there may be a minimum fitness level needed beyond which the heart can bounce back from the strain of training and running a long race. Furthermore, these results emphasize the need for proper preparation before recreational distance runners engage in a marathon race,” he concludes.
This study was supported in part by grants from the Heart and Stroke Foundation of Canada (Quebec) and the Quebec Heart Institute Foundation.
# # #
Notes for editors
“Transient Myocardial Tissue and Function Changes During a Marathon in Less Fit Marathon Runners,” by Valerie Gaudreault, MD, MSc, FRCPC, Helena Tizon-Marcos, MD, Paul Poirier, MD, PhD, FRCPC, FAHA, FACC, Philippe Pibarot, DVM, PhD, FACC, FAHA, Philippe Gilbert, MD, FRCPC, Marc Amyot, MSc, Josep Rodés-Cabau, MD, FESC, Jean-Pierre Després, PhD, FACC, FAHA, Olivier Bertrand, MD, PhD, and Eric Larose, DVM, MD, FRCPC, FAHA, Canadian Journal of Cardiology, Volume 29/Issue 10 (October 2013), http://dx.doi.org/10.1016/j.cjca.2013.04.022, published by Elsevier.
Full text of the article is available to credentialed journalists upon request. Contact Eileen Leahy at +1 732 238 3628 or email@example.com to obtain copies. Journalists wishing to set up interviews with the authors should contact Dr. Eric Larose at +1 418 656 8711 extension 3917 or firstname.lastname@example.org.
About the Canadian Journal of Cardiology
The Canadian Journal of Cardiology (www.onlinecjc.ca) is the official journal of the Canadian Cardiovascular Society (www.ccs.ca). It is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as a major venue for the results of Canadian cardiovascular research and Society guidelines. The journal publishes original reports of clinical and basic research relevant to cardiovascular medicine as well as editorials, review articles, case reports, and papers on health outcomes, policy research, ethics, medical history, and political issues affecting practice.
About the editor-in-chief
Editor-in-Chief Stanley Nattel, MD, is Paul-David Chair in Cardiovascular Electrophysiology and Professor of Medicine at the University of Montreal and Director of the Electrophysiology Research Program at the Montreal Heart Institute Research Center.
About the Canadian Cardiovascular Society
The Canadian Cardiovascular Society is the professional association for Canadian cardiovascular physicians and scientists working to promote cardiovascular health and care through knowledge translation, professional development, and leadership in health policy. The CCS provides programs and services to its 1900+ members and others in the cardiovascular community, including guidelines for cardiovascular care, the annual Canadian Cardiovascular Congress, and, with the Canadian Cardiovascular Academy, programs for trainees. More information about the CCS and its activities can be found at www.ccs.ca.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
+1 732 238 3628